Needle-Free Injection Device market was valued at US$ 206.4 million in 2022 and is anticipated to reach US$ 402.7 million by 2029, witnessing a CAGR of 9.9% - Valuates Reports

Needle-Free Injection Device market was valued at US$ 206.4 million in 2022 and is anticipated to reach US$ 402.7 million by 2029, witnessing a CAGR of 9.9% during the forecast period 2023-2029.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-14N14198/Global_Needle_Free_Injection_Device_Market_Research_Report_2023

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.

This report aims to provide a comprehensive presentation of the global market for Needle-Free Injection Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Injection Device.
The Needle-Free Injection Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Needle-Free Injection Device market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Injection Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Segment by Type
Powder Injections
Liquid Injections
Depot or Projectile Injection

Segment by Application
Drug Injection
Cosmetic Surgery Use
Other

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-14N14198/global-needle-free-injection-device

Similar report -

https://reports.valuates.com/market-reports/QYRE-Auto-32Z11552/global-jet-needleless-injector

https://reports.valuates.com/market-reports/QYRE-Auto-38D6399/global-needle-free-drug-injection-systems

https://reports.valuates.com/market-reports/QYRE-Auto-9I7099/global-intramuscular-injector

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

This release was published on openPR.